Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 423INDUSTRY 92NIH 80NETWORK 42OTHER_GOV 6UNKNOWN 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Triple Negative Breast Neoplasms 3Breast Neoplasms 2

Interventions

Paclitaxel 7Epirubicin 7Capecitabine 7pyrotinib 5Docetaxel 5Carboplatin 5Vinorelbine 4Fulvestrant 4Cyclophosphamide 4exemestane 3anlotinib 3Radiotherapy 3Radiation Dose Hypofractionation 3Etoposide 3pirarubicin 2palbociclib 2apatinib 2Standard of Care 2Neoadjuvant Therapy 2Letrozole 2Albumin-Bound Paclitaxel 2toripalimab 1titanium silicide 1nimotuzumab 1neratinib 1lobaplatin 1liposomal doxorubicin 1icaritin 1eribulin 1Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
UNKNOWN × Cyclophosphamide × Breast × Clear all
NCT05287308 2022-03-31

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

ChineseAMS

Phase NA Not yet recruiting
500 enrolled
Breast

Breast Neoplasms

NCT04437160 2020-06-18

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

ChineseAMS

Phase 2 Recruiting
286 enrolled
Breast

Triple Negative Breast Neoplasms

NCT03876886 2019-03-21

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

ChineseAMS

Phase 3 Unknown
200 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

ChineseAMS

Phase 3 Unknown
100 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡